Differences between FIT in screening and symptomatic use
Find out the differences in the use of the Faecal Immunochemical test for bowel cancer screening and for people with symptoms.
Cancers of the large bowel (colon)and back passage (rectum). Also called colorectal cancer or large bowel cancer.
Find out the differences in the use of the Faecal Immunochemical test for bowel cancer screening and for people with symptoms.
Supports healthcare professional decision-making with top tips on referral guidelines, safety netting and repeat FIT.
This study is using pharmacists to give out FIT tests to help find bowel cancer early.
This study is looking to see if a new blood test can help to spot cancer early.
This study is looking at exercise and diet to help reduce muscle loss in people with advanced bowel cancer.
This trial is looking at pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for cancer that has spread to the peritoneum or primary peritoneal cancer
Read about the Be Clear on Cancer campaigns in England and Wales to support bowel cancer screening uptake.
This study is comparing genetic testing at home with genetic testing in hospital.
This trial is looking at MK-2870 by itself or in combination with other drugs for some cancers of the digestive system.
This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for solid cancers that have spread (advanced cancer).